Keep a close watch on updates from FMCG companies, the cement sector, from real estate companies, especially about the commercial segment o...

The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...

At CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...

Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...

Amid rising tariffs and geopolitical tensions, trade negotiations between India and the United States have reached an impasse. The US has v...

Indian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...

India and China are working to improve their diplomatic relations following past military tensions over border disputes. Recent measures in...

Bayer has announced a significant investment of $2.2 billion to establish a new pharmaceutical site in New Albany, Ohio. This project follo...

The Supreme Court has questioned steep markups on cancer drugs and asked the Centre to examine a uniform 16% margin on all medicines. The c...

Indian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...

The Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...

The United States has announced it will exempt certain speciality drugs and ingredients imported from India and 19 other countries from tar...

The Central Drugs Standard Control Organisation is addressing regulatory gaps related to the illegal diversion of pharmaceutical drugs. Fol...

Novartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...

India's pharmaceutical sector is projected to grow at 11-13 percent this fiscal year due to export increases. The domestic market is also e...

Supreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...

HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...